HUGE News and Press, FSD Pharma Inc. From 04/23/21

Management director nominees bring superior experience and expertise to drive positive growth, represent ALL shareholders interests and create value for ALL shareholders. FSD's COVID-19 FDA trials gaining momentum.  Management actively pursuing multi...

FSD Pharma Inc. Management Wasting Company Money by Seeking to Further Delay Shareholder Meeting PR Newswire TORONTO , April 5, 2021 /PRNewswire/ - On Tuesday, March 30, 2021 , Anthony Durkacz , a founding director and member of the group of concerned sha...

- Proceedings intended to appeal elements of Ontario Commercial List decision and challenge dissidents over material conflicts of interest and disclosure deficiencies - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”)...

FSD Pharma is a biopharmaceutical research company specializing in medical applications of cannabinoids. The company found a possible treatment for COVID-19 and is attempting a Phase II study. The company is undertaking another study for the treatment of illness in cats and dogs u...

Translate Bio (TBIO) -26% after Translate Bio’s Cystic Fibrosis therapy fails to improve lung function in Phase 1/2 trial.PhaseBio Pharmaceuticals (PHAS) -14% on equity raise.Broadway Financial (BYFC) -13% after stockholders of Broadway Financial and CFBan...

Gainers: Zhongchao (ZCMD) +53%, Immatics (IMTX) +42%, Lipocine (LPCN) +23%, FSD Pharma (HUGE) +18%, Nabriva Therapeutics (NBRV) +18%.Losers: SunLink Health Systems (SSY) -28%, Rubius Therapeutics (RUBY) -17%, CHF Solutions CHFS&...

FSD Pharma (HUGE) soars 56% premarket after entering into a license agreement with Innovet Italia S.R.L., under which Innovet granted the Company a license to use ultramicronized-palmitoylethanolamide to develop FDA approved veterinary drugs for the treatment of gastro-intestinal di...

-Announces Filing of Year-End 2020 Results and Provides Corporate Update FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces that it has entered into a license agreement (the “License Agreement”...

Toronto, Ontario--(Newsfile Corp. - March 8, 2021) - The group of concerned shareholders (the " Concerned Shareholders ") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) (the " Company " or " FSD ") which includes two founding directors, Anthony Durkacz and Zeeshan Saeed, are pleased ...

Mexico with 121 million citizens will likely legalize cannabis by April of this year opening the door to the largest population for potential customers; This will be a game-changing tipping point for legalization of cannabis around the world and especially throughout Latin America; ...